Background: There is a considerable amount of literature on the potential relationship between human leukocyte antigen-G 14-bp Ins/Del polymorphism and virus infection; however, results from these studies were inconclusive.
Introduction
Human leukocyte antigen (HLA)-G was first reported to be a key player in maintaining maternal-fetal immune tolerance. [1] It has been shown that expression level of HLA-G increases significantly during pathological states, such as in tumors, autoimmune diseases, and infectious diseases. HLA-G has been implicated in viral infections, as its tolerogenic function mediates escape of the virus from host immune defenses. [2] [3] [4] The immune suppressive mechanism of HLA-G includes inhibition of cytotoxic activity of natural killer and cytotoxic T cells, CD4+ T cell alloproliferative response, and dendritic cells maturation. [5] The HLA-G gene is located on chromosome 6p21.3, and comprises 7 introns and 8 exons.
[6] A 14-base pairs (14-bp) insertion/deletion (Ins/Del) polymorphism (rs66554220) in the 3 0 untranslated region(UTR) of the HLA-G gene has been associated with mRNA stability and splicing patterns, which has an impact on protein levels. [7, 8] To date, there has been little agreement on the association between HLA-G 14-bp Ins/Del polymorphism and susceptibility to viral infections. Some studies have linked HLA-G 14-bp Ins/Del polymorphism with human cytomegalovirus (HCMV) and human T-lymphotropic virus type 1 (HTLV-1) infections. [9] [10] [11] [12] Other studies indicated that there is no association between HLA-G 14-bp Ins/Del polymorphism and virus infections. [13] [14] [15] [16] [17] [18] Since these results were inconclusive, we decided to perform a systematic review to assess the relationship between HLA-G 14-bp Ins/Del polymorphism and virus infections.
Materials and methods

Ethical considerations
All analyses were based on previous published studies; thus no ethical approval and patient consent are required.
Search strategy
We searched for relevant literatures using the PubMed and Web of Science databases; the search terms used were: "HLA-G OR human leukocyte antigen-G" AND "polymorphism OR variant OR mutation" AND "virus OR viruses"; no language restriction was applied.
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Study selection criteria
Inclusion criteria for the studies were as follows: studies that investigated the correlation between the 14-bp Ins/Del polymorphism and virus infection; results included sufficient genotype data to determine the odds ratio (OR) and 95% CI; (3) study design was case controlled. Exclusion criteria were as follows: letters, reviews; duplicated data.
Data extraction
Two researchers extracted qualified data; extracted information included the first authors' names, year of publication, ethnicity, virus type, the number of cases and controls, and evidence of Hardy-Weinberg equilibrium (HWE) in controls. We resolved discrepancies through discussions.
Statistics
Based on the raw information, we calculated the HWE of HLA-G 14-bp Ins/Del polymorphism in the control group via the Chisquare test. The STATA version 12.0 software was used to perform the meta-analysis. An odds ratio with 95% CI was used to evaluate the significance of association between HLA-G 14-bp Ins/Del and susceptibility to viral infections. A random-effect or fixed-effect model was used, depending on the degree of heterogeneity. The pooled OR with the corresponding 95% CI were calculated in a recessive model (Ins/Ins vs Ins/Del + Del/Del), a dominant model (Ins/Ins + Ins/Del vs Del/Del), homozygote comparison (Del/Del vs Ins/Ins), and allele comparison (Ins vs Del). Subgroup analyses were performed according to virus type (only one study would be incorporated into the "other virus" group) and ethnicity (categorized as Asian, Africa, and Mixed population).
The I 2 test was used to assess the effects of heterogeneity. [19] I 2 > 25% indicated heterogeneity among the included studies.
When I 2 statistic was > 25%, the random-effect DerSimonianLaird method was used [19] ; otherwise, the fixed-effect MantelHaenszel method was used. [20] To evaluate the significance of the pooled OR, the Z test was carried out, and P < .05 was considered to be statistically significant.
Furthermore, sensitivity analysis was conducted to determine the effects of individual studies on the pooled susceptibility to virus by consecutively excluding single studies. Lastly, funnel plots and asymmetrical tests were performed to assess publication bias.
Results
Characteristics of eligible studies
A total of 177 publications were screened from databases. Figure 1 shows the study selection procedure; 10 articles, including 1835 patients and 2357 controls were ultimately selected. The specific characteristics of the qualified reports are presented in Table 1 . The included focused on the following virus types: hepatitis B virus (HBV), [11, 15, 16] HTLV-1, [9, 10] human papillomavirus (HPV), [17, 18] HCMV, [12] hepatitis C virus (HCV), [13] and human immunodeficiency virus (HIV). [14] 3.2. Meta-analysis of HLA-G 14-bp Ins/Del polymorphism and virus infection
Results of the meta-analysis are shown in Table 2 . The I 2 test demonstrated distinct heterogeneity in the selected studies in 4 genetic models. Therefore, the random effect model was applied to generate a larger pool of studies with 95% CI. As shown in Fig. 2D ). However, subgroup analysis based on virus type showed that the polymorphism was significantly associated with HTLV-1 infection in the dominant model (OR = 0.61, 95% CI = 0.42-0.90, P < .05) ( Table 2) . Similarly, there was significant association between HLA-G 14-bp Ins/Del polymorphism and Mixed population in ethnicity-based subgroup analysis in the dominant model (OR = 0.79, 95% CI = 0.67-0.94, P < .01).
Tests for sensitivity and publication bias
Among the included literatures, one did not meet the HWE; however, sensitivity analysis showed that there was no significant change to the pooled OR (data was not shown). This suggested that our analyses are comparatively stable and reliable. We obtained Begg's funnel plots in all 4 models (Fig. 3) . Harbord's tests demonstrated no evidence of publication bias in the 4 models (P > .1)
Discussions
HLA-G is known as an important immune regulatory molecule that facilitates virus infection, and mediates tumor cell escape from host immunological surveillance by inhibiting immune cells functions. [18] Polymorphism of HLA-G 14-bp Ins/Del was shown to be associated with mRNA stability and splicing patterns, which may have an impact on the expression of HLA-G protein. [7, 8] To date, few studies have been able to conduct systematic research on this issue. The current study systemically reviewed the relationship between HLA-G 14-bp Ins/Del and virus susceptibility. We carried out this meta-analysis with 10 articles, which included 1835 cases and 2357 controls. The results implied that HLA-G 14-bp Ins/Del polymorphism may not have a significant effect on virus susceptibility in any comparison models. Further stratification analyses based on virus type and ethnicity revealed no significant associations between HBV, HPV, and other viruses in Asian and African population. However, we found evidence of significant association between HTLV-1 and Mixed population in a dominant model. It is possible that the non-allelic interaction and host genes may be associated with persistence of virus infection. Xu et al [18] showed that the relationship between 14-bp Ins/+3142G haplotype and HPV18 infection risk was prominent in a previous study. In addition, higher frequency of the 14-bp Ins /+3142G haplotype was observed in African-derived HIV positive patients when compared with that in controls. [14] Table 2 Meta-analysis of the associations between the HLA-G 14-bp polymorphism and virus susceptibility in 4 genetic models.
Dominant model
Recessive model DD vs II D vs I OR odds ratio, 95% CI 95% confidence interval. HBV = hepatitis B virus, HPV = human papillomavirus, HTLV-1 = human T-lymphotropic virus type 1. * A significant result. † The statistical significance of the pooled OR was determined by the Z test. ‡ No statistical significance was found by the heterogeneity test, then the fixed-effects model was adopted here, otherwise, random-effect will be employed. Table 1 Genotype and allele distribution of the HLA-G 14-bp Ins/Del polymorphism in patients with virus infection diseases and controls. [13] 2017 HBV  Mixed  32  99  66  45  87  70  163 231 177 227 0.08 Laaribi [10] 2014 HBV  Africa  87  109  67  63  113  70  283 243 239 253 0.21 Jiang [6] 2011 HBV HCC  Asian  12  66  144  68  208  263  90 354 344 734 0.01 Haddad [5] 2011 HTLV-1  Mixed  18  82  38  29  67  54  118 158 125 175 0.32 Ciliao Alves [4] 2016 HTLV- To apply the interpretations obtained from the current metaanalysis, certain limitations should be considered. First, the number of included studies was not big enough, which set a limit to perform further subgroup analyses. Second, aside from disease susceptibility, polymorphism at HLA-G 14-bp may be associated with clinical features. Due to a lack of adequate data, we were unable to analyze possible confounding factors, such as age, sex, virological, immunological, or environmental variables, which may have an effect on the progression of the disease. Third, although no evidence of publication bias was observed in Harbord's test, publication bias is unavoidable in meta-analyses. There were only total 10 studies on viral infection included in this meta-analysis; 3 studies on HBV, 2 studies on HPV, 2 studies on HTLV-1, and a single study on each of HCMV, HIV, and HCV.
Conclusion
Overall, our study demonstrated that HLA-G 14-bp Ins/Del polymorphism may exert no influence on susceptibility to viruses. However, due to the limited number of studies examined, some results from the current meta-analysis are limited. In the future, larger eligible studies are required to investigate the gene-gene and gene-environment interactions on HLA-G gene polymorphism in viral diseases. This may provide a more comprehensive and reliable foundation for etiological research, and promote clinical prevention of virus infection.
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